Targeted Therapies Grant

Overview

date/time interval

• September 30, 2022 - September 29, 2024

awarded by

• United States Department of Defense 

administered by

• Medicine-Hematology and Medical Oncology

sponsor award ID

• W81XWH-22-2-0018

Affiliation

contributor

• Nanus, David M   Co-Investigator   2022 - 2023
• Tagawa, Scott T.   Principal Investigator   2022 - 2023